Literature DB >> 1384027

Conjunctival penetration of insulin and peptide drugs in the albino rabbit.

E Hayakawa1, D S Chien, K Inagaki, A Yamamoto, W Wang, V H Lee.   

Abstract

An in vitro model was used to evaluate the conjunctival penetration of three peptides, [D-ala2]metenkephalinamide (YAGFM, MW 647), substance P (MW 1348), and insulin (MW 5778), in comparison with two nonpeptides, atenolol (MW 266) and timolol (MW 433). All three peptides were hydrolyzed to varying extents during penetration across the conjunctiva. The permeability coefficient for intact YAGFM and insulin was 4.5 +/- 0.3 and 4.6 +/- 0.7 microns sec-1, respectively. These values were about two to five times lower than those for atenolol and timolol. No permeability coefficient could be calculated for substance P, since its transconjunctival flux never reached steady state. The conjunctival penetration of YAGFM and insulin was improved by about two and three times, respectively, with the addition of 1% Na glycocholate. Increasing the Na glycocholate concentration was more effective than changing the type of bile salt in improving the conjunctival penetration of insulin. The maximum factor of improvement was 12, as the Na glycocholate concentration was raised to 4%. The way in which Na deoxycholate, glycocholate, and taurocholate affected the conjunctival penetration of atenolol, timolol, and insulin suggests that these three bile salts improved mainly the transcellular penetration of the compounds studied.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384027     DOI: 10.1023/a:1015803605621

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  The normal surface of conjunctiva epithelium. A scanning electron microscopic study.

Authors:  R R Pfister
Journal:  Invest Ophthalmol       Date:  1975-04

2.  IN VITRO ION AND WATER MOVEMENT IN CORNEAS OF RAINBOW TROUT.

Authors:  H F EDELHAUSER; J R HOFFERT; P O FROMM
Journal:  Invest Ophthalmol       Date:  1965-06

3.  Effects of anionic surfactants on hamster small intestinal membrane structure and function: relationship to surface activity.

Authors:  G W Gullikson; W S Cline; V Lorenzsonn; L Benz; W A Olsen; P Bass
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

4.  Demonstration of the mucous layer of the tear film by electron microscopy.

Authors:  B A Nichols; M L Chiappino; C R Dawson
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

5.  Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.

Authors:  V H Lee; D S Chien; H Sasaki
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

6.  Interaction of beta-cyclodextrin with bile salts in aqueous solutions.

Authors:  K Miyajima; M Yokoi; H Komatsu; M Nakagaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-03       Impact factor: 1.645

7.  Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes.

Authors:  A Yamamoto; E Hayakawa; V H Lee
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

8.  Hydrolysis of enkephalins in homogenates of anterior segment tissues of the albino rabbit eye.

Authors:  S D Kashi; V H Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-08       Impact factor: 4.799

9.  Systemic absorption of ocularly administered enkephalinamide and inulin in the albino rabbit: extent, pathways, and vehicle effects.

Authors:  R E Stratford; L W Carson; S Dodda-Kashi; V H Lee
Journal:  J Pharm Sci       Date:  1988-10       Impact factor: 3.534

10.  The ocular route for systemic insulin delivery in the albino rabbit.

Authors:  A Yamamoto; A M Luo; S Dodda-Kashi; V H Lee
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

View more
  5 in total

1.  Polar solute transport across the pigmented rabbit conjunctiva: size dependence and the influence of 8-bromo cyclic adenosine monophosphate.

Authors:  Y Horibe; K Hosoya; K J Kim; T Ogiso; V H Lee
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

2.  Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.

Authors:  Y B Chung; K Han; A Nishiura; V H Lee
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

3.  Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers.

Authors:  H Sasaki; Y Igarashi; T Nagano; K Nishida; J Nakamura
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

Review 4.  In Vitro Cell Models for Ophthalmic Drug Development Applications.

Authors:  Sara Shafaie; Victoria Hutter; Michael T Cook; Marc B Brown; David Y S Chau
Journal:  Biores Open Access       Date:  2016-04-01

Review 5.  Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors:  Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal:  Pharmaceutics       Date:  2018-02-27       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.